Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.
about
A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma.Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.Diagnosis and prognosis-review of biomarkers for mesothelioma.New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.
P2860
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Plasma Biomarker Enrichment of ...... alignant Pleural Mesothelioma.
@en
Plasma Biomarker Enrichment of ...... alignant Pleural Mesothelioma.
@nl
type
label
Plasma Biomarker Enrichment of ...... alignant Pleural Mesothelioma.
@en
Plasma Biomarker Enrichment of ...... alignant Pleural Mesothelioma.
@nl
prefLabel
Plasma Biomarker Enrichment of ...... alignant Pleural Mesothelioma.
@en
Plasma Biomarker Enrichment of ...... alignant Pleural Mesothelioma.
@nl
P2093
P2860
P50
P1476
Plasma Biomarker Enrichment of ...... alignant Pleural Mesothelioma.
@en
P2093
Abraham Chachoua
Antoinette Wozniak
Chandra Goparaju
Devalben Patel
Jessica Donington
Michele Carbone
Natasha Leighl
Osvaldo Espin-Garcia
Ronald Feld
P2860
P304
P356
10.1016/J.JTHO.2016.02.006
P577
2016-02-21T00:00:00Z